1 to 9 of 35 results

Teva receives subpoenas over Copaxone and Azilect marketing

Teva receives subpoenas over Copaxone and Azilect marketing


The US Department of Justice is investigating Israel drugmaker Teva Pharmaceutical Industries’ marketing…

AzilectCopaxoneLegalMarkets & MarketingNeurologicalPharmaceuticalTeva Pharmaceutical Industries

Teva gains favorable court ruling in Azilect patent case

Teva gains favorable court ruling in Azilect patent case


Israel-based Teva Pharmaceutical Industries has gained a favorable ruling in its patent infringement…

AzilectGenericsLegalMylan LaboratoriesNeurologicalNorth AmericaTeva Pharmaceutical Industries

ANN meeting highlights: Novartis' Gilenya, Lundbeck's Azilect, Orion's ODM-101, Biotie's tozadenant


Among the highlights of the annual meeting of the American Academy of Neurology taking place in San Diego,…

AzilectBiotie TherapiesGilenyaLundbeckNeurologicalNovartisODM-101Orion CorpPharmaceuticalResearchTeva Pharmaceutical Industriestozadenant

Patient share of Teva/Lundbeck's Azilect for Parkinson's continues to grow


Through examination of US patient-level claims data, that patient share of Azilect (rasagiline) - from…

AzilectLundbeckMarkets & MarketingNeurologicalNorth AmericaPharmaceuticalTeva Pharmaceutical Industries

Teva gets EU clearance for Cephalon acquisition; negative review on Azilect


Following US antitrust clearance last week, Israel-based Teva Pharmaceutical Industries (Nasdaq: TEVA)…

AzilectCephalonMergers & AcquisitionsNeurologicalPharmaceuticalRegulationTeva Pharmaceutical Industries

Variations in Parkinson's disease treatment among prescribers in France, Germany, Italy, Spain and the UK


When comparing dopamine agonist use for Parkinson's disease, more frequent use of once-daily formulations…

AzilectBoehringer IngelheimFranceGermanyGlaxoSmithKlineItalyLundbeckMarkets & MarketingMirapexNeurologicalPharmaceuticalRequipTeva Pharmaceutical IndustriesUK

Watson in partnership with Moksha8 for Brazil and Mexico, inc $30M investment; files for generic Azilect


US specialty and generics drugmaker Watson Pharmaceuticals (NYSE: WPI) has entered an accord with Moksha8,…

AzilectGenericsLicensingMergers & AcquisitionsMoksha8NeurologicalNorth AmericaPharmaceuticalRegulationSouth AmericaTeva Pharmaceutical IndustriesWatson Pharmaceuticals

1 to 9 of 35 results

Back to top